Amgen accused of monopolizing market for parathyroid treatment
MLex Summary: Macleods Pharmaceuticals filed counterclaims against Amgen in a patent infringement case brought by the Amgen. Macleods is seeking a declaratory judgment finding that Amgen violated antitrust law by bring...To view the full article, register now.
Already a subscriber? Click here to view full article